Article
ESR1 polymorphisms were associated with aromatase inhibitors induced musculoskeletal symptoms in breast cancer patients.
Breast cancer research and treatment - 18 Mar 2026
Jing Feng, Jiang Lingyun, Cao Yuling, Tian Maoting, Qiu Jiajia, Tang Lichen, Hu Yan
Abstract excerpt
PURPOSE: Aromatase Inhibitors Associated Musculoskeletal Symptoms (AIMSS) are common side effects among hormone receptor-positive breast cancer patients, significantly affecting patients' treatment adherence and quality of life. The individual genetic susceptibility mechanism underlying AIMSS was not well understood yet. This study aimed to validate the association between genetic polymorphisms and AIMSS among...
Topics
- Humans
- Female
- Aromatase Inhibitors
- Breast Neoplasms
- Estrogen Receptor alpha
- Middle Aged
- Polymorphism, Single Nucleotide
- Cross-Sectional Studies
- Adult
- Genetic Predisposition to Disease
